newsfilter
← Latest News
PR Newswire·

Synaptogenix Announces Regenerative Patent Award to Treat Alzheimer's Disease

NEW YORK, July 7, 2021 /PRNewswire/ -- Synaptogenix, Inc. (NASDAQ:SNPX), an emerging biopharmaceutical company focused on developing therapies for neurodegenerative diseases, today announced that a new patent has been awarded by the U.S. Patent and Tra